| 1. | The first, vismodegib, was FDA-approved in 2012, for treating basal cell carcinoma.
|
| 2. | Basal cell carcinoma is the most common type of skin cancer,
|
| 3. | There is little evidence that it is effective in preventing basal cell carcinoma.
|
| 4. | When the pathway malfunctions, it can result in diseases like basal cell carcinoma.
|
| 5. | Basal cell carcinomas rarely spread and deaths from them are rare.
|
| 6. | Basal cell carcinoma, Squamous cell carcinoma ) and melanoma skin cancers in moles.
|
| 7. | Physical findings typically include follicular atrophoderma, multiple basal cell carcinomas, hypotrichosis, and hypohidrosis.
|
| 8. | Pathology results confirmed basal cell carcinoma, the most curable form of skin cancer.
|
| 9. | Furthermore, overexpression of PTCH2 does not replace mutated PTCH1 in basal cell carcinoma.
|
| 10. | Basal cell carcinoma is the most curable form of skin cancer.
|
मोबाइल